1
|
Hu ZY, Chen XY, Yang X, Li T, Yang YS, Wang SJ, Wang K, Hu ZG. Imaging and detection of sulfite in acute liver injury with a novel quinoxaline-based fluorescent probe. Anal Chim Acta 2023; 1261:341177. [PMID: 37147051 DOI: 10.1016/j.aca.2023.341177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2023] [Revised: 03/23/2023] [Accepted: 04/04/2023] [Indexed: 05/07/2023]
Abstract
Herein, a novel fluorescent probe HZY was developed for monitoring the sulfite (SO32-) dynamics. For the first time, the SO32- triggered implement was applied in the acute liver injury (ALI) model. The levulinate was selected to achieve the specific and relatively steady recognition reaction. With the addition of SO32-, the fluorescence response of HZY exhibited a large Stokes shift of 110 nm under the 380 nm excitation. The merits included high selectivity under various pH conditions. Compared with the reported fluorescent probes for sulfite, HZY indicated above-moderate performances including remarkable and rapid response (40 folds, within 15 min), and high sensitivity (limit of detection = 0.21 μM). Further, HZY could visualize the exogenous and endogenous SO32- level in living cells. Moreover, HZY could gauge the changing levels of SO32- in three types (induced by CCl4, APAP, and alcohol) of ALI models. Both in vivo imaging and depth-of-penetration fluorescence imaging demonstrated that HZY could characterize the developmental and therapeutic status during the liver injury process by measuring the dynamic of SO32-. The successful implementation of this project would promote the accurate in-situ detection of SO32- in liver injury, which was expected to guide the pre-clinical diagnosis and clinical practice.
Collapse
Affiliation(s)
- Ze-Yang Hu
- Department of Immunology, Institute of Laboratory Medicine, Jiangsu Key Laboratory for Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, 212013, China
| | - Xu-Yang Chen
- Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Qingyang Road 299, Wuxi, 214023, China
| | - Xue Yang
- Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Qingyang Road 299, Wuxi, 214023, China
| | - Ting Li
- Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Qingyang Road 299, Wuxi, 214023, China
| | - Yu-Shun Yang
- Jinhua Advanced Research Institute, Jinhua, 321019, China
| | - Sheng-Jun Wang
- Department of Immunology, Institute of Laboratory Medicine, Jiangsu Key Laboratory for Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, 212013, China.
| | - Kai Wang
- Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Qingyang Road 299, Wuxi, 214023, China.
| | - Zhi-Gang Hu
- Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Qingyang Road 299, Wuxi, 214023, China.
| |
Collapse
|
2
|
Rubio NR, Fish KD, Trimmer BA, Kaplan DL. Possibilities for Engineered Insect Tissue as a Food Source. FRONTIERS IN SUSTAINABLE FOOD SYSTEMS 2019. [DOI: 10.3389/fsufs.2019.00024] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
|
3
|
Xu S, Jiang R, Mueller R, Hoesli N, Kretz T, Bowers J, Chen H. Probing lactate metabolism variations in large-scale bioreactors. Biotechnol Prog 2018; 34:756-766. [DOI: 10.1002/btpr.2620] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2017] [Revised: 01/03/2018] [Indexed: 01/09/2023]
Affiliation(s)
- Sen Xu
- Upstream Process Development and Engineering, Biologics Process Development & Clinical Manufacturing; Merck & Co., Inc.; Kenilworth NJ
| | - Rubin Jiang
- Upstream Process Development and Engineering, Biologics Process Development & Clinical Manufacturing; Merck & Co., Inc.; Kenilworth NJ
| | - Roland Mueller
- Biologics Process Development & Clinical Manufacturing; MSD Werthenstein BioPharma GmbH; Schachen Switzerland
| | - Nadja Hoesli
- Biologics Process Development & Clinical Manufacturing; MSD Werthenstein BioPharma GmbH; Schachen Switzerland
| | - Thomas Kretz
- Biologics Process Development & Clinical Manufacturing; MSD Werthenstein BioPharma GmbH; Schachen Switzerland
| | - John Bowers
- Bioprocess Technical Operations, Biologics Process Development & Clinical Manufacturing; Merck & Co., Inc.; Kenilworth NJ
| | - Hao Chen
- Upstream Process Development and Engineering, Biologics Process Development & Clinical Manufacturing; Merck & Co., Inc.; Kenilworth NJ
| |
Collapse
|